Related Experiment Video
Updated: May 15, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Drug-induced immune thrombocytopenia due to moxifloxacin
1Ehrling Bergquist Family Medicine Residency, Offutt AFB, Nebraska, USA. timothy.coker@us.af.mil
Abstract:
A 39-year-old woman with 1 day of oral petechiae, leg ecchymoses and epistaxis was found to have isolated thrombocytopenia. She had recently completed a 10-day course of moxifloxacin for an upper respiratory infection. On further questioning, she had developed thrombocytopenia 2 years earlier after a treatment course with moxifloxacin. After ruling out other causes, drug-induced immune thrombocytopenia due to moxifloxacin was diagnosed. Her platelets returned to normal range 15 days after finishing the medication.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Allergic Reactions
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Drug–Drug Interaction
